Illumina and Pillar Biosciences partner to improve access to personalized cancer treatment options
/PRNewswire/ -- Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, and Pillar Biosciences Inc., the pioneers of...